Jonathan Fitzsimmons
Brookhaven National Lab Upton, USA
Biography
Jonathan Fitzsimmons completed his master from Johns Hopkins University in 2000, and received his PhD in radiochemistry in 2005 from University of Missouri-Columbia. He performed postdoctoral studies at Los Alamos National Laboratory and research at the University of North Carolina at Chapel Hill. He is currently a medical scientist at Brookhaven National Laboratory, where he developed a production scale separation of 68Ge, and is part of the TriLab team to develop 225Ac on a production scale. He has published over ten papers in reputed journals, has one patent and is serving on an expert panel for the US Pharmacopeia.
Abstract
Abstract : When beta therapy fails – Is alpha therapy a solution?
